Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 78 | 3 | 2 | 1 | €258.60 | €331.61 | 28.234% |
| Eli Lilly Corp. | 72 | 2 | 7 | 1 | €799.00 | €991.05 | 24.037% |
| Gilead Sciences Inc | 54 | 0 | 2 | 0 | €118.42 | €124.33 | 4.993% |
| Intuitive Surgical Inc | 54 | 2 | 3 | 0 | €382.70 | €523.55 | 36.804% |
| Vertex Pharmaceuticals Inc. | 47 | 0 | 2 | 0 | €367.40 | €461.98 | 25.742% |
| HCA Holdings Inc. | 45 | 0 | 0 | 0 | €422.60 | €448.99 | 6.244% |
| Regeneron Pharmaceuticals Inc. | 45 | 1 | 3 | 0 | €638.70 | €707.12 | 10.712% |
| Dexcom Inc. | 43 | 1 | 1 | 0 | €54.40 | €77.13 | 41.783% |
| Johnson & Johnson | 41 | 1 | 7 | 0 | €202.75 | €215.09 | 6.088% |
| Cigna Corp. | 37 | 0 | 0 | 0 | €229.30 | €311.96 | 36.049% |
| Medtronic plc | 37 | 1 | 4 | 0 | €74.20 | €95.57 | 28.801% |
| Thermo Fisher Scientific Inc. | 35 | 0 | 1 | 0 | €419.40 | €504.64 | 20.325% |
| AbbVie Inc. | 33 | 0 | 3 | 0 | €178.40 | €208.89 | 17.089% |
| Amgen Inc. | 34 | 3 | 1 | 0 | €298.35 | €305.71 | 2.468% |
| Edwards Lifesciences Corp. | 31 | 0 | 1 | 0 | €66.24 | €80.91 | 22.149% |
| Biogen Inc. | 29 | 0 | 4 | 0 | €148.66 | €181.48 | 22.079% |
| BioMarin Pharmaceutical Inc. | 28 | 0 | 1 | 0 | €46.50 | €80.63 | 73.405% |
| Agilent Technologies Inc. | 27 | 0 | 0 | 0 | €97.96 | €139.61 | 42.514% |
| Elanco Animal Health Inc. | 23 | 0 | 0 | 0 | €19.95 | €23.60 | 18.322% |
| Stryker Corp. | 22 | 0 | 1 | 0 | €287.00 | €364.34 | 26.949% |
| Exact Sciences | 22 | 0 | 0 | 0 | €90.74 | - | - |
| Teva Pharmaceutical Industries Ltd ADR | 22 | 0 | 1 | 0 | €26.00 | €31.83 | 22.426% |
| Align Technology | 21 | 0 | 1 | 0 | €146.20 | €175.92 | 20.328% |
| Resmed Inc. | 19 | 0 | 1 | 0 | €192.00 | €258.40 | 34.581% |
| Merck & Co. Inc. | 17 | 0 | 2 | 0 | €102.94 | €115.68 | 12.378% |